LOG IN
SIGN UP
News
OABI
3.210
-3.60%
-0.120
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
TipRanks · 03/08 14:53
OmniAb: Legitimate Competition To AbCellera In Antibody Discovery
Seeking Alpha · 02/27 17:16
Ligand's (LGND) Q4 Sales & Earnings Top, View Raised, Stock Up
NASDAQ · 02/23 12:49
OmniAb a new buy at Cowen on pure-play antibody drug discovery platform
Seeking Alpha · 02/22 15:16
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Benzinga · 02/22 15:00
Cowen & Co. Initiates Coverage On OmniAb with Outperform Rating, Announces Price Target of $10
Benzinga · 02/22 11:01
Cowen Initiates OmniAb at Outperform With $10 Price Target
Cowen Initiates OmniAb at Outperform With $10 Price Target
MT Newswires · 02/22 08:01
OmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnerships
Seeking Alpha · 02/13 19:18
Analysts Offer Insights on Services Companies: OmniAb (OABI) and Flux Power Holdings (FLUX)
TipRanks · 02/13 11:20
HC Wainwright & Co. Initiates Coverage On OmniAb with Buy Rating, Announces Price Target of $11
Benzinga · 02/13 11:17
--HC Wainwright Starts OmniAb at Buy With $11 Price Target
--HC Wainwright Starts OmniAb at Buy With $11 Price Target
MT Newswires · 02/13 07:22
Bumbershoot Holdings 2022 Investor Letter
Seeking Alpha · 02/12 06:15
BRIEF-Omniab Inc Preliminary Unaudited Cash Cash Equivalents And Marketable Securities As Of Dec 31 2022 About $88 Mln
Reuters · 01/09 22:06
Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
Benzinga · 12/20/2022 15:01
--Truist Starts OmniAb at Buy With $10 Price Target
--Truist Starts OmniAb at Buy With $10 Price Target
MT Newswires · 12/20/2022 09:02
Some 'Transgenic Animal Platforms Are More Than Equal,' Analyst Initiating Coverage On OmniAb Says
Benzinga · 12/16/2022 17:39
Credit Suisse Initiates Coverage On OmniAb with Outperform Rating, Announces Price Target of $13
Benzinga · 12/16/2022 13:30
--Credit Suisse Initiates OmniAb at Outperform Rating With $13 Price Target
--Credit Suisse Initiates OmniAb at Outperform Rating With $13 Price Target
MT Newswires · 12/16/2022 09:25
Insider Buy: Omniab
Insider Buy: Omniab
MT Newswires · 12/14/2022 17:10
$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying
Benzinga · 12/02/2022 13:43
More
Webull provides a variety of real-time OABI stock news. You can receive the latest news about OmniAb, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About OABI
OmniAb, Inc. operates as a discovery platform that provides pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable the discovery of next-generation therapeutics. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. Its OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach and OmniTaur features structural attributes of cow antibodies for complex targets. The Company's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic targets.